三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库！
欢迎来到三个皮匠报告！
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置：
首页
>
行业数据
>
KRAS（ON）抑制剂机理
KRAS（ON）抑制剂机理
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式：PNG
图片大小：289KB
图片尺寸：1135*770
同报告图片
/
4
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
所属报告：
【华金证券】医药行业周报：KARS抑制剂：肿瘤治疗的蓝海赛道-260105（19页）.pdf
打包全文图表
相关数据
JAK抑制剂在骨髓纤维化治疗中的竞争格局
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
收藏
竞争格局
2026-06-26
原图定位
查看详情
《KAT6抑制剂化合物、药物组合物及其制备方法和N-(6-((1H-pyrazol-1-yl)methyl)-4-metho
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
收藏
行业数据
2026-05-11
原图定位
查看详情
图10、全球PD-(L)1抑制剂市场规模（十亿美元）
fCDlubTku70gICB8IOW4guWcuuinhOaooe+8iOWNgeS6v+e+juWFg++8iSB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMjUgQSB8IDY3LjkgICAgICAgICAgICAgICAgIHwKfCAyMDI2IEUgfCDvvIjmnKrmmI7noa7moIfms6jlhbfkvZPmlbDlgLzvvIzlm77ooajkuK3lrZjlnKjlr7nlupTmn7HlvaLvvIkgfAp8IDIwMjcgRiB8IO+8iOacquaYjuehruagh+azqOWFt+S9k+aVsOWAvO+8jOWbvuihqOS4reWtmOWcqOWvueW6lOafseW9ou+8iSB8CnwgMjAyOCBGIHwg77yI5pyq5piO56Gu5qCH5rOo5YW35L2T5pWw5YC877yM5Zu+6KGo5Lit5a2Y5Zyo5a+55bqU5p+x5b2i77yJIHwKfCAyMDI5IEYgfCDvvIjmnKrmmI7noa7moIfms6jlhbfkvZPmlbDlgLzvvIzlm77ooajkuK3lrZjlnKjlr7nlupTmn7HlvaLvvIkgfAp8IDIwMzAgRiB8IDEyNS43ICAgICAgICAgICAgICAgIHwKfCAyMDMxIEYgfCDvvIjmnKrmmI7noa7moIfms6jlhbfkvZPmlbDlgLzvvIzlm77ooajkuK3lrZjlnKjlr7nlupTmn7HlvaLvvIkgfAp8IDIwMzIgRiB8IO+8iOacquaYjuehruagh+azqOWFt+S9k+aVsOWAvO+8jOWbvuihqOS4reWtmOWcqOWvueW6lOafseW9ou+8iSB8CnwgMjAzMyBGIHwg77yI5pyq5piO56Gu5qCH5rOo5YW35L2T5pWw5YC877yM5Zu+6KGo5Lit5a2Y5Zyo5a+55bqU5p+x5b2i77yJIHwKfCAyMDM0IEYgfCDvvIjmnKrmmI7noa7moIfms6jlhbfkvZPmlbDlgLzvvIzlm77ooajkuK3lrZjlnKjlr7nlupTmn7HlvaLvvIkgfAp8IDIwMzUgRiB8IO+8iOacquaYjuehruagh+azqOWFt+S9k+aVsOWAvO+8jOWbvuihqOS4reWtmOWcqOWvueW6lOafseW9ou+8iSB8CnwgMjAzNiBGIHwgMjYzLjAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaRk1JIOaKpeWRiu+8jOWFtOS4muivgeWIuOe7j+a1juS4jumHkeiejeeglOeptumZouaVtOeQhg==
收藏
市场规模
2026-05-11
原图定位
查看详情
图10.VMAT2抑制剂全球销售情况（亿美元）
收藏
行业数据
2026-04-20
原图定位
查看详情
全球PCSK9抑制剂市场规模（亿美元）
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
收藏
市场规模
2026-04-13
原图定位
查看详情
中国PCSK9抑制剂市场规模（亿人民币）
收藏
市场规模
2026-04-13
原图定位
查看详情
相较于PD-(L)1抑制剂，PD-(L)1/VEGF双抗有极大替代和拓展空间
收藏
行业数据
2026-03-31
原图定位
查看详情
全球在研FXI/FXIa抑制剂的临床进展
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
收藏
行业数据
2026-02-26
原图定位
查看详情
FXI/FXIa抑制剂全球可触及患者数
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
收藏
行业数据
2026-02-26
原图定位
查看详情
图表11FDA获批KRASG12C抑制剂的全球销售额（百万美元）
收藏
行业数据
2026-02-25
原图定位
查看详情
图表19KRASG12D抑制剂竞争格局
收藏
竞争格局
2026-02-25
原图定位
查看详情
图3 mCRC中EGFR抑制剂的美国收入（2004-2017）
收藏
行业数据
2026-02-13
原图定位
查看详情
主要JAK抑制剂全球销售额
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
收藏
行业数据
2026-01-30
原图定位
查看详情
国内主要JAK抑制剂在研格局
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
收藏
竞争格局
2026-01-30
原图定位
查看详情
JAK抑制剂：国内样本医院销售额
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
收藏
行业数据
2026-01-30
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模（百万美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
KRAS G12D（ON）的 RMC-9805 等。相关研究表明，这些药物可能比 KRAS（OFF）抑制剂更有效。
行业数据
原图定位
当前图表所属：
【华金证券】医药行业周报：KARS抑制剂：肿瘤治疗的蓝海赛道-260105（19页）.pdf
JAB-23E73的BiochemicalActivities
AN-9025部分临床前数据
RMC-6236的生化和细胞活性
RMC-6236的临床试验情况
下载图片或Excel，需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利，扫码领取！
关注公众号『三个皮匠报告』，免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码？
验证即登录，未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》
研搜
0731-84720580
商务合作：really158d
下载Excel
下载图片
原图定位
打包全文图表
收藏
2026-06-26
原图定位
微信扫码登录
手机快捷登录
账号登录
